Toll-like receptors impact on safety and efficacy of gene transfer vectors.

Innate immune responses are triggered when pattern-recognition receptors recognize specific conserved patterns on pathogens. The most extensively studied pattern-recognition receptors are toll-like receptors (TLRs), which are comprised of 11 different receptors, named TLR1-11. TLRs recognize motifs that are found on a wide range of pathogens, and activation of TLRs results in the production of large amounts of type I interferons and several proinflammatory cytokines. These cytokine responses are important in controlling pathogen replication and they also provide an initiation signal for the adaptive immune response. Although numerous manuscripts have reviewed the important role of TLRs in host defense against wild-type viruses, bacteria, and/or their subcomponents, none have focused on how TLRs recognize commonly utilized gene delivery vehicles such as adenovirus and adeno-associated virus (AAV) vectors. In this review, we discuss our understanding of how TLRs are activated by gene transfer vectors.

[1]  J. Rodgers,et al.  Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Ruslan Medzhitov,et al.  Control of B-cell responses by Toll-like receptors , 2005, Nature.

[4]  R. Bronson,et al.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[5]  T. Libermann,et al.  Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. , 1999, Human gene therapy.

[6]  S. Akira,et al.  TRAM is specifically involved in the Toll-like receptor 4–mediated MyD88-independent signaling pathway , 2003, Nature Immunology.

[7]  R. Graham,et al.  Activation of host antitumoral responses by cationic lipid/DNA complexes , 2000, Cancer Gene Therapy.

[8]  A. Kiang,et al.  Adenovirus Infection Triggers a Rapid, MyD88-Regulated Transcriptome Response Critical to Acute-Phase and Adaptive Immune Responses In Vivo , 2006, Journal of Virology.

[9]  M. Frank,et al.  Recombinant adenovirus vectors activate the alternative complement pathway, leading to the binding of human complement protein C3 independent of anti-ad antibodies. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  S. Akira,et al.  Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.

[11]  A. Aderem,et al.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Theresa A. Storm,et al.  Unrestricted Hepatocyte Transduction with Adeno-Associated Virus Serotype 8 Vectors in Mice , 2005, Journal of Virology.

[13]  R. Samulski,et al.  Role of viral vectors and virion shells in cellular gene expression. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  J. Wilson,et al.  Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  A. Aderem,et al.  The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens , 1999, Nature.

[16]  J. Schoggins,et al.  Sensing Infection by Adenovirus: Toll-Like Receptor-Independent Viral DNA Recognition Signals Activation of the Interferon Regulatory Factor 3 Master Regulator , 2007, Journal of Virology.

[17]  R. Scheule,et al.  Antitumor activity of cationic lipid complexed with immunostimulatory DNA. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  R. Morgan,et al.  Toxicity of a first-generation adenoviral vector in rhesus macaques. , 2002, Human gene therapy.

[19]  A. Kiang,et al.  Multiple innate inflammatory responses induced after systemic adenovirus vector delivery depend on a functional complement system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[20]  B. Monks,et al.  TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.

[21]  S. Akira,et al.  Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation. , 2002, International immunology.

[22]  S. Akira,et al.  Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. , 2004, Blood.

[23]  H. Mizukami,et al.  A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. , 2001, Human gene therapy.

[24]  P. Colarusso,et al.  The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. , 2003, Human Gene Therapy.

[25]  S. Tapscott,et al.  Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy. , 2006, Human gene therapy.

[26]  S. Ross,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a Retrovirus , 2004, Journal of Virology.

[27]  S. Akira,et al.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.

[28]  S. Hensley,et al.  Dendritic Cell Maturation, but Not CD8+ T Cell Induction, Is Dependent on Type I IFN Signaling during Vaccination with Adenovirus Vectors1 , 2005, The Journal of Immunology.

[29]  Ruslan Medzhitov,et al.  Toll-like receptors: linking innate and adaptive immunity. , 2005, Advances in experimental medicine and biology.

[30]  D. Liggitt,et al.  Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. , 1999, Journal of immunology.

[31]  A. J. Roman,et al.  Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[32]  N. Wong,et al.  Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors , 2002, Journal of Virology.

[33]  P. Seth,et al.  The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. , 2002, Human gene therapy.

[34]  James M. Wilson,et al.  Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers , 1998, Journal of Virology.

[35]  D. Koeberl,et al.  Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  M. Magnusson,et al.  The Maturation of Murine Dendritic Cells Induced by Human Adenovirus Is Mediated by the Fiber Knob Domain* , 2003, Journal of Biological Chemistry.

[37]  Y. Péréon,et al.  Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium , 2007, Gene Therapy.

[38]  James M. Wilson,et al.  Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.

[39]  S. Akira,et al.  Toll-like receptors control activation of adaptive immune responses , 2001, Nature Immunology.

[40]  S. Akira,et al.  The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1 , 2003, The Journal of Immunology.

[41]  T. Libermann,et al.  Adenovirus Vector-Induced Expression of the C-X-C Chemokine IP-10 Is Mediated through Capsid-Dependent Activation of NF-κB , 2000, Journal of Virology.

[42]  Atsuko Negishi,et al.  Development and Characterization of Novel Empty Adenovirus Capsids and Their Impact on Cellular Gene Expression , 2003, Journal of Virology.

[43]  Xiaopei Huang,et al.  Innate Immune Response to Adenoviral Vectors Is Mediated by both Toll-Like Receptor-Dependent and -Independent Pathways , 2007, Journal of Virology.

[44]  E. P. Black,et al.  Adenoviral infection induces a multi-faceted innate cellular immune response that is mediated by the toll-like receptor pathway in A549 cells. , 2007, Virology.

[45]  Jiahuai Han,et al.  Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.

[46]  R. Scheule,et al.  Long-term transgene expression from plasmid DNA gene therapy vectors is negatively affected by CpG dinucleotides. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  A. Thomson,et al.  Recombinant Adenovirus Induces Maturation of Dendritic Cells via an NF-κB-Dependent Pathway , 2000, Journal of Virology.

[48]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[49]  D. Klinman,et al.  Contribution of CpG motifs to the immunogenicity of DNA vaccines. , 1997, Journal of immunology.

[50]  S. Akira,et al.  Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.

[51]  B. Williams,et al.  Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  S. Akira,et al.  Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.

[53]  Qiang Liu,et al.  Molecular basis of the inflammatory response to adenovirus vectors , 2003, Gene Therapy.

[54]  A. Yamamoto,et al.  Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells 1 , 2003, The Journal of Immunology.

[55]  S. Akira,et al.  Endotoxin-Induced Maturation of MyD88-Deficient Dendritic Cells1 , 2001, The Journal of Immunology.

[56]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[57]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[58]  S. Akira,et al.  Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.

[59]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[60]  T. Libermann,et al.  Adenovirus vector-induced inflammation: capsid-dependent induction of the C-C chemokine RANTES requires NF-kappa B. , 2002, Human gene therapy.

[61]  S. Akira,et al.  The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.

[62]  Meredith O'Keeffe,et al.  Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9‐dependent maturation and IFN‐α production , 2006, The journal of gene medicine.

[63]  S. Akira,et al.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. , 2004, Immunity.

[64]  Akiko Iwasaki,et al.  Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[65]  R. Medzhitov,et al.  Toll-like receptors and their ligands. , 2002, Current topics in microbiology and immunology.

[66]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[67]  L. Babiuk,et al.  TLR9−/− and TLR9+/+ mice display similar immune responses to a DNA vaccine , 2004, Immunology.

[68]  S. Akira,et al.  Activation of Toll-Like Receptor-2 by Glycosylphosphatidylinositol Anchors from a Protozoan Parasite1 , 2001, The Journal of Immunology.

[69]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[70]  A. Beaudet,et al.  Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. , 2004, Human gene therapy.

[71]  S. Ross,et al.  Murine retroviruses activate B cells via interaction with toll-like receptor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  I. Kovesdi,et al.  Adenovirus infection stimulates the Raf/MAPK signaling pathway and induces interleukin-8 expression , 1997, Journal of virology.

[73]  C. Walker,et al.  Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D , 1997, Journal of virology.

[74]  James M. Allen,et al.  Systemic delivery of genes to striated muscles using adeno-associated viral vectors , 2004, Nature Medicine.

[75]  M. Hollenberg,et al.  Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10 , 2002, Journal of Virology.

[76]  H. Ertl,et al.  CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[77]  H. Wagner,et al.  Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.

[78]  M. Greenblatt,et al.  A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004, Science.

[79]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[80]  R. Wilmott,et al.  Replication-deficient adenovirus induces expression of interleukin-8 by airway epithelial cells in vitro. , 1995, Human gene therapy.

[81]  Ravi A. Desai,et al.  Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid , 2006, Nature Medicine.

[82]  P. Boulanger,et al.  Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response , 2002, Journal of Virology.

[83]  B. Lemaître,et al.  The Dorsoventral Regulatory Gene Cassette spätzle/Toll/cactus Controls the Potent Antifungal Response in Drosophila Adults , 1996, Cell.

[84]  S. Force,et al.  Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. , 2000, Cancer research.

[85]  Katherine A. High,et al.  Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector , 1999, Nature Medicine.

[86]  A. Iwasaki,et al.  Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.

[87]  Feng Liu,et al.  Non‐immunostimulatory nonviral vectors , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[88]  G. Nemerow,et al.  Preferential Activation of Toll-Like Receptor Nine by CD46-Utilizing Adenoviruses , 2006, Journal of Virology.

[89]  N. Philpott,et al.  Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[90]  S. Akira,et al.  Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.